Megestrol Acetate
Product Images NDC 81646-120

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 81646-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pinnacle Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is The Structure (Megestrol Acetate Suspension 1)

Chemical structure of Megestrol Acetate showing its steroidal framework with acetyl ester functional group and ketone groups as depicted in the molecular diagram.*

FDA Label Image

Trial 1 (Megestrol Acetate Suspension 2)

A line graph labeled 'TRIAL 1' showing mean weight change in pounds on the vertical axis and time in weeks on the horizontal axis. The graph compares four groups: 800 mg, 400 mg, 100 mg doses, and placebo, with weight changes increasing over 12 weeks for all doses except placebo which shows minimal change.*

FDA Label Image

Trial 2 (Megestrol Acetate Suspension 3)

Line graph titled TRIAL 2 depicting mean weight change in pounds over 12 weeks. The x-axis shows weeks (0, 4, 8, 12) and the y-axis shows mean weight change from -3 to 12 pounds. Two lines represent weight changes for 800 mg dose and placebo groups, with the 800 mg group showing steady weight gain and the placebo group showing initial slight gain followed by weight loss.*

FDA Label Image

Cup Label (Megestrol Acetate Suspension 4)

Label for Megestrol Acetate oral suspension 400 mg per 10 mL, distributed by Pinnacle Pharma LLC. The label states prescription use only and a 10 mL delivery volume. It includes expiration date 04/22/2021, lot number 123456, and manufacturer lot 1322301, with a hazard warning.*

FDA Label Image

Case Label (Megestrol Acetate Suspension 5)

Label for Megestrol Acetate oral suspension 400 mg/10 mL by Pinnacle Pharma LLC. The dosage form is liquid suspension with a quantity of 72 cups, each cup containing 5 mL. The label includes storage instructions to keep at controlled room temperature (20° to 25°C), and it highlights the product as hazardous.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.